Gas Embolism during Hysteroscopic Surgery Detected by Esophageal Echocardiography: A comparison using two different electrocautery cutting techniques.

Paradoxical and venous Gas Embolism During Hysteroscopic Surgery Detected by Trans Esophageal Echocardiography: A comparison using either bipolar or monopolar diathermia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON23264

Enrollment

Registered

2008-06-25

Start date

2008-10-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To determine the incidence and grade of venous emboli and/or paradoxical gas emboli during hysteroscopy surgery. In addition, a comparison will be made using either bipolar or monopolar diathermia. Knowing the incidence and severity of embolic events may help in understanding the pathophysiology and thereby help in preventing these potentially lethal events. keywords: hysteroscopy, paradoxical emboli, venous emboli, trans oesophageal echocardiography. In Dutch: hysteroscopie, veneuze gasemboli

Interventions

Patients will be subjected to hysteroscopy using either mono or bipolar diathermia. Under general anaesthesia a transoesophageal echocardiography probe will be inserted in all patients to observe an

Eligibility

Inclusion criteria

Inclusion criteria: Healthy patients (ASA classification 1 or 2) scheduled for Trans Cervical Myoma resection (TCR-M) or Trans Cervical endometrium resection (TCR-E) will be included.

Exclusion criteria

Exclusion criteria: Exclusion criteria include age younger than 18 or higher than 70 and a history of pulmonary embolism, cardiac disease or oesophageal disease.

Design outcomes

Primary

Measure	Time frame
Percentage venous or paradoxical emboli	—

Secondary

Measure	Time frame
Duration of emboli observation	—

Contacts

Public ContactB.M.P. Rademaker

Onze Lieve Vrouwe Gasthuis Oosterpark 9

b.m.p.rademaker@olvg.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)